Patients are enrolled from 2 tertiary care institutions if they meet inclusion criteria ( stable estimated glomerular filtration rate ( eGFR ) between 15-45ml / min , < 5ml/min change in previous 6 months ) , on stable doses of renin-angiotensin aldosterone system blockade .